Pharmacokinetics of enrofloxacin after intravenous, intramuscular and oral administration in houbara bustard (Chlamydotis undulata macqueenii)

Journal of Veterinary Pharmacology and Therapeutics

Volumn 21, Issue 4, 1998, Pages 288-297

  Bailey, T A ^a,b   Sheen, R S ^c   Silvanose, C ^a   Samour, J H ^a   Garner, A ^c   Harron, D W G ^c  

^a National Avian Research Center AbuDhabi   (United Arab Emirates)

^b UNIVERSITY OF KENT   (United Kingdom)

^c UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

ENROFLOXACIN;

ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISPOSITION; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANIMALIA; ARDEOTIS KORI; AVES; BACTERIA (MICROORGANISMS); CHLAMYDOTIS; CHLAMYDOTIS UNDULATA; CHLAMYDOTIS UNDULATA MACQUEENII; KLEBSIELLA; OTIDIDAE; PSEUDOMONAS; SALMONELLA; STAPHYLOCOCCI;

EID: 0031880754     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.1998.00143.x     Document Type: Article

References (51)

1. Anadon, A., Martinez-Larranaga, M.R., Diaz. M.J., Bringas, P., Martinez. M.A. & Fernandez-Cruz, M.L. (1995) Pharmacokinetics and residues of enrofloxacin in chickens. American Journal of Veterinary Research, 56, 501-506.
2. R Broad-spectrum antiinfective for the treatment of bacterial diseases in animals. Product information. pp. 27. Bayer Veterinary Department. Leverkusen, Germany.
3. th edn. Ed. Adams, H. R. pp. 18-52. Iowa State University Press, Ames.
4. Bailey, T.A., Mensah-Brown. E., Samour. J.H., Naldo, J., Lawrence, P. & Garner, A. (1997a) Comparative morphology of the alimentary tract, including its glandular derivatives, of captive bustards. Journal of Anatomy, 191, 387-398.
5. Bailey, T.A., Nicholls, P.K., Samour. J.H., Howlett, J.C. & Wernery, U. (1996) Post-mortem findings of bustards in the United Arab Emirates. Avian Diseases, 40, 296-305.
6. Bailey, T.A., Wernery. U., Naldo, J. & Samour,. J.H. (1997b) Plasma concentration of creatine kinase and lactate dehydrogenase in captive houbara bustards (Chlamydotis unduIata macqueenii) following capture. Comparative Haematology International 7, 113-116.
7. Bauditz. R. (1987) Results of clinical studies with Baytril in poultry. Veterinary Medical Review. 2, 130-136.
8. Blaser, J., Stone. B.B., Groner. M.C. & Zinner, S.H. (1987) Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrobial Agents and Chemotherapy. 31, 1054-1060.
9. Brown, S.A. (1996) Fluoroquinolones in animal health. Journal of Veterinary Pharmacology and Therapeutics. 19, 1-14
10. Brown, D.F.J. & Brown. L. (1991) Evaluation of the R-test, a novel way of quantifying antimi1crobial activity. Journal of Antimicrobial Chemotherapy. 27, 185-190.
11. Cambau. E. & Gutmann. L. (1993) Mechanisms of resistance to quinolones. Drugs, 45, 15-23.
12. Chen, Z., Fung. K.-F., Fang. B. & Song, Y. (1994) Antimicrobial and pharmacokinetic studies of fluoroquinolones in chickens. In Proceedings of the Sixth Congress of the European Association for Veterinary Pharmacology and Toxicology, Ed. Lees. P., pp. 209-210, Edinburgh, 7-11 August. Blackwell Scientific Publications, Oxford.
13. Conzelman. G.M., Babish, J.G., Davidson, J.N., McMillan, R.A. & Copeland. D.D. (1987) Pharmacokinetics of 1-cyclopropyl-6-fluoro-1. 4-dihydro-4-oxo - 7 [4-ethyl-1-piperazinyl]-3-quinoline carboxylic acid (CFPQ) in chickens. Proceedings of the Western Pharmacology Society 30, 593-395. Hawaii, 18-23 January.
14. Conzelman, G.M., McMillan, R.A. & Baggot, J.D. (1986) Pharmacokinetics of 1-cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo - 7 [4-ethyl- 1-piperazinyl]-3-quinoline carboxylic acid (CFPQ) in turkeys. Proceedings of the Western Pharmacology Society 29, 321-323. Alberta. Canada, 23-28 February.
15. Dorrestein, G.M. (1991) The pharmacokinetics of avian therapeutics. Veterinary Clinics of North America, Small Animal Practice. 21, 1241-1263.
16. Dorrestein, G.M. (1993) Antimicrobial drug use in pet birds. In Antimicrobial therapy in veterinary medicine. Eds Prescott. J.F. & Baggot, J.D. pp. 490-506. Iowa State University Press. Ames.
17. Dorrestein, G.M. & Van Miert, A.S.J.P.A.M. (1988) Pharmacotherapeutic aspects of medication of birds. Journal of Veterinary Pharmacology and Therapeutics, 11, 33-44.
18. Dorrestein, G.M. & Verburg, E. (1988) Pharmacokinetics of enrofloxacin (Baytril) in homing-pigeons after different administration routes. In Proceedings of the Fourth Congress of the European Association for Veterinary Pharmacology and Toxicology. pp. 172. Budapest, Hungary.
19. Drusano, G.L. & Goldstein. F.W. (1996) Relevance of the Alexander Project: pharmacodynamic considerations. Journal of Antimicrobial Chemotherapy, 38, 141-154.
20. Dunne, A. & King, P. (1989) Estimation of noncompartmental parameters: a technical note. Journal of Pharmacokinetic Biopharmacology, 17, 131-137.
21. Fernandes, P.B. (1988) Mode of action, and in vitro and in vivo activities of the fluoroquinolones. Journal of Clinical Pharmacology. 28, 156-168.
22. Flammer, K. (1990) An update of psittacine antimicrobial pharmacokinetics. In Proceedings of the Association of Avian Veterinarians, pp. 218-220. 10-15 September, Phoenix. Arizona.
23. Flammer, K. (1992) New advances in avian therapeutics. In Proceedings of the Association of Avian Veterinarians, pp. 14-18. New Orleans.
24. Flammer. K. (1995) Antimicrobial therapy. In Avian Medicine: principles and application. Eds Ritchie. B.W., Harrison, G.J. & Marrison. L.R., pp. 454-456, Wingers Publishing, Florida.
25. Flammer, K. & Aucoin. D.P. (1992) Clinical use and pharmacokinetics of Baytril in caged birds. Baytril Symposium, Bonn, pp. 59-61.
26. Flammer, K., Aucoin, D.P. & Whitt, D.A. (1991) Intramuscular and oral disposition of enrofloxacin in African grey parrots following single, and multiple doses. Journal of Veterinary Pharmacology and Therapeutics, 14, 559-566.
27. Forrest. A., Nix. D.E., Ballow. C.H., Goss. T.F., Birmingham. M.C. & Schentag, J.J. (1993) Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrobial Agents and Chemotherapy, 37, 1073-1081.
28. Haesebrouck. F., Vanrobacys, M., De Herdt, P. & Ducatelle, R. (1995) Effect of antimicrobial treatment on the course experimental Yersinia pseudotuberculosis infection in canaries. Avian Pathology, 24, 273-283.
29. Hyatt, J.M., McKinnon, P.S., Zimmer, G.S. & Schentag. J.J. (1995), The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Clinical Pharmacokinetics, 28, 143-169.
30. Kararli, T.T. (1989) Gastrointestinal absorption of drugs. Critical Reviews in Therapeutic Drug Carrier Systems, 6, 39-85.
31. Kietzmann, M., Knoll, U. & Glünden. G. (1997) Pharmacokineics of enrofloxacin and danofloxacin in broiler chickens. Journal of Veterinary Pharmacology and Therapeutics , Supplement. 1, 202.
32. Koneman, E.W., Allen, S.D., Janda, W.M., Schreckenberger, P.C. & Winn. W.C. (1992) Colour atlas of diagnostic microbiology. 4th edn. J. B. Lippencott Company, Philadelphia.
33. Krautwald, M.E., Pieper. K., Rullof. R., Schmahl, C., Gobel, T.H. & Kaleta, E. (1990) Further experiences with the use of Baytril in pet birds. In Proceedings of the Association of Avian Veterinarians, pp. 226-236.
34. Küng. K., Riond, J.-L. & Wanner, M. (1993) Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. Journal of Veterinary Pharmacology and Therapeutics, 16, 462-468.
35. Lindenstruth, H. & Frost. J.W. (1993) Enrofloxacin (Baytril) - an alternative for official prophylaxis and treatment of psittacosis in imported psittacine birds. Deutsche Tierarztliche Wochenschrift, 100, 364-368.
36. Lumeij, J.T. (1995) Psittacine antimicrobial therapy. In Antimicrobial therapy in caged and exotic pets, an international symposium, pp. 38-48. North American Veterinary Conference, Florida.
37. Mähler. M., Stünkel, S., Ziegowski, C. & Kunstyr, I. (1994) Ineflicacy of enrofloxacin in the elimination of Pasteurella multocida in rabbits. Laboratory Animals, 29, 192-199.
38. Marshall, S.A., Jones. R.A., Wanger, A., Washington, J.A., Doern, G.V., Leber, A.L. & Haugen, T.H. (1996) Proposed MIC quality control guidelines for National Committee for Clinical Laboratory Standards Susceptibility Tests using seven veterinary antimicrobial agents: ceftiofur, enrofloxacin, florflenicol, penicillin G-novobiocin. pirlimycin, premafloxacin, and spectinomycin. Journal of Clinical Microbiology. 34, 2027-2029.
39. Ostrowski, S., Greth, A. & Mikaelian, I. (1996) Pathology and veterinary care. In Propagation of the houbara bustard. Eds Saint Jalme. M. & Van Heezik, Y., pp. 70-96. Kegan Paul International, London.
40. Ritchie, B.W. & Harrison, G.J. (1995) Formulary. In Avian Medicine: principles and application. Eds Ritchie, B.W., Harrison, G.J. & Harrison, L.R., pp. 457-478. Wingers Publishing, Florida.
41. Scheer, M. (1987a) Studies on the antibacterial activity of Baytril. Veterinary Medical Review, 2, 90-99.
42. Scheer, M. (1987b) Concentrations of active ingredient in the serum and in the tissues after oral and parenteral administration of Baytril. Veterinary Medical Review, 2, 104-118.
43. Scheer, M., Froyman, R., de Jong, A. & Altreuther, P. (1997) Antibacterial sensitivity monitoring of avian Escherichia coli isolates over five years. Journal of Veterinary Pharmacology and Therapeutics, Supplement. 1, 189.
44. Semjen. G. & Blasko. E. (1994) In-vitro emergence of resistance to flumequine and enrofloxacin in strains of Staphylococcus aureus. In Proceedings of the Sixth Congress of the European Association for Veterinary Pharmacology and Toxicology, Ed. Lees. P., pp. 239-240. Edinburgh, 7-11 August. Blackwell Scientific Publications, Oxford.
45. Shumaker, R.C. (1986) PKCALX: a BASIC interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metabolism Reviews, 17, 331-348.
46. Sleigh. I. & Samour, J.S. (1996) The National Avian Research Center Bird Care Manual. National Avian Research Center Internal Research Report no. 41, Abu Dhabi.
47. th edn. Ed. Adams. H.R., pp. 820-854. Ames, Iowa State University Press.
48. Tigar, B.J. (1995) Preliminary study of the rate of passage of digesta in the houbara bustard. National Avian Research Center Internal Research Report no. 24. Abu Dhabi, p. 5.
49. Turbahn, A., Cortez de Jäckel, S., Greuel, E., de Jong. A., Froyman. R. & Kaleta, E.F. (1997) Dose response study of enrofloxacin against Riemerella anatipestifer septicaemia in Muscovy and Pekin ducklings. Avian Pathology. 26, 791-802.
50. Vancutsem, P.M., Babish, J.G. & Schwark. W.S. (1990) The fluoroquinolone antimicrobials: structure, antimicrobial activity, pharmacokinetics. clinical use in domestic animais and toxicity. Cornell Veterinarian. 80, 173-186.
51. Watts, J.L., Salmon, S.A., Yancey, R.J., Neressian, B. & Kounev, Z.V. (1993) Minimum inhibitory concentrations of bacteria isolated from septicemia and airsacculitis in ducks, Journal of Veterinary Diagnostic Investigation. 5, 625-628.